Fresenius Medical Care AG (FMS) Cash & Equivalents (2009 - 2025)

Fresenius Medical Care AG's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $1.9 billion for Q4 2025.

• In Q4 2025, Cash & Equivalents rose 47.61% year-over-year to $1.9 billion; the TTM figure through Dec 2025 stood at $1.9 billion (up 47.61% YoY), while the FY2025 annual figure was $1.9 billion, up 47.61% from the prior year.
• Cash & Equivalents was $1.9 billion for Q4 2025 at Fresenius Medical Care AG, up from $1.4 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.9 billion in Q2 2025 to a low of $1.2 billion in Q1 2025.
• Historically, Cash & Equivalents has averaged $1.5 billion across 5 years, with a median of $1.4 billion in 2022.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents declined 23.33% in 2022, then jumped 47.61% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $1.7 billion in 2021, then dropped by 23.33% to $1.3 billion in 2022, then climbed by 18.16% to $1.5 billion in 2023, then slipped by 17.89% to $1.3 billion in 2024, then surged by 47.61% to $1.9 billion in 2025.
• The last three Cash & Equivalents figures came in at $1.9 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.9 billion (Q2 2025), per Business Quant data.